leena-menghaney_msfbackground_credit-msf-access-campaign

2 July 2018Asia

LSIPR 50 2018: Levelling the medicines playing field

Generic production in India has become vital to the supply of quality and affordable medicines to people in the developing world. But with a population of 1.3 billion people, and many living in poverty, India is a country where many need, but don’t have, access to medicine.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Bayer gains exclusive licence for heart drug in Japan

GSK triumphs in EPO appeal, revoking Pfizer patent

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

MSN scores win in battle with Novartis over heart drug generic

President Xi sends message to AIPPI’s World Congress

LSIPR 50 2018: Levelling the medicines playing field

Editor's picks

Editor's picks

More features